PharmaShots’ Top 20 Healthcare IPOs of 2024 report, backed by DealForma insights, highlights how healthcare companies raised significant capital—led by Galderma’s $2.54B IPO—underscoring key funding trends, strategic growth, and market impact across biopharma and healthcare services. Read it here
